Effect of antimalarial drugs on the bioavailability of the methylenediphosphonic acid labeled with technetium99m (99mTc-MDP) in Wistar rats

Brazilian Archives of Biology and Technology

Volumn 49, Issue 2, 2006, Pages 207-214

  Holanda, Cecília Maria De Carvalho Xavier ^a   Leite, Rodrigo De Carvalho Holanda ^b   Nunes, Reginauro Alves Da Silva ^b   De Oliveira, Harina Alves ^b   Catanho, Maria Teresa Jansen De Almeida ^c   De Souza, Grace Mary Lima ^c   Bernardo Filho, Mário ^d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b Utad Universidade Federal do Rio Grande do Morte (UFRN)   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

99mTc MDP; Antimalarial drugs; Artemisinin; Drug interaction; Mefloquine; Radiopharmaceuticals

Indexed keywords

RATTUS NORVEGICUS;

EID: 33746601164     PISSN: 15168913     EISSN: 15168913     Source Type: Journal    
DOI: 10.1590/s1516-89132006000300004     Document Type: Article

References (36)

1. Amorim, L. F.; Xavier Holanda, C. M. C.; Catanho, M. T.; Terra, D. A.; Brandão, K. C.; Jales-Jr., L. H.; Britto, L. M. L.; Gomes, M. L.; Melo, V. G.; Bernardo-Filho, M. and Jales, R. L. C. L. (2003), Assessment of the effect of Punica granatum (pomegranate) on the bioavailability of the radiopharmaceutical sodium pertechnetate (99mTc) in Wistar rats. Cell. Mol. Biol., 49: (4), 501-7.
2. Bremen, J. (2001), The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg., 64: (1/2), 1-11.
3. Britto, L. M. L.; Xavier Holanda, C. M. C.; Jales, R. L. C.; Marques, F. M. H.; Jales-Jr., L. H.; Brandão, K. C.; Amorim, L. F. and Bernardo-Filho, M. (2004), Effects of tamoxifen on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats. J. Animal Veterinary Advances, 3: (4), 208-212.
4. th ed. New York: Williams and Wilkins.
5. 99mTc- methylene diphosphonate (MDP)-gentamicin interaction. J. Nucl. Biol. Med., 38: (4- Suppl. 1), 132-134.
6. Cronhjort, M.; Saaf, M.; Sjoberg, H. E.; Schnell, P. O. and Jacobsson, H. (1998), Influence of the phosphate balance on the activity distribution of 99mTc-hidroxymethylene diphosphonate. Experimental studies in the mouse. Acta Radiol., 39: (4), 427-433.
7. Early, P. J. and Sodee, D. B. (1996), Principles and Practice of Nuclear Medicine. Toronto: Mosby-Year Book Inc.
8. -99m- methylenediphosphonic acid in balb/c mice. Nucl. Med. Commun., 19, 1177-1179.
9. Gomes, M. L.; Mattos, D. M. M.; Freitas, R. S.; Diré, G. F.; Lima, E. A. C.; Souza, S. M. and Bernardo-Filho, M. (2002), Evaluation of the effect of mitomicin-C on the bioavailability of technetium-99m labeled sodium pyrophosphate in mice. Cell. Mol. Biol., 48: (7), 757-759.
10. Harbert, J. C.; Eckelman, W. C. and Neumann, R. D. (1996), Nuclear Medicine Diagnosis and Therapy. New York: Thieme Medical Publ.
11. Hesslewood, S. and Leung, E. (1994), Drugs interactions with radiopharmaceuticals. Eur. J. Nucl. Med., 21, 348-356.
12. Hladik III, W. B.; Saha, G. B. and Study, K. T. (1987), Essentials of Nuclear Medicine Science. London: Williams and Wilkins.
13. Hojelse, C.; Kristensen, K. and Sampson, C. B. (1994), Factors which affect the integrity of radiopharmaceuticals. In: Sampson, C. B. (Ed.). Textbook of Radiopharmacy Theory and Practice. London: Williams and Wilkins. pp. 145-151.
14. Hung, G. L.; James, A. P. and Hammes, R. J. (1996), Radiopharmaceuticals related pitfalls and artifacts. Semin. Nucl. Med., 26, 208-255.
15. Jales Jr., L. H.; Xavier Holanda, C. M. C.; Ramos, A. M. O.; Jales, R. L. C.; Britto, P. L. J.; Jales, R. D.; Jales- Neto, H.; Viana, L. S. A. A.; Teixeira, M. L.; Catanho, M. T. J.; Leite, R. C. H.; Britto, L. M. L.; Brandão, K. C.; Amorim, L. F. and Bernardo-Filho, M. (2004), Influence of the morphine on the kinetic of biodistribution of technetium-99m labeled with MDP in Wistar rats. J. Animal Veterinary Advances, 3: (5), 306-310.
16. Klayman, D. L. (1985), Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228, 1049-1055.
17. 99mTc-phytate in Balb/c mice. In: Nicolini, M. and Mazzi, U. (Eds.). Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine. Podova: Servizi Grafici. pp. 465-472.
18. Meshnick, S. R. and Dobson, M. J. (2001), The history of antimalarial drugs. In: Rosenthal, P. J. (Ed.). Antimalarial chemotherapy. Mechanism of Action, Resistance and New Directions in Drug Discovery. Totowa, New Jersey: Humana. pp. 15-25.
19. Miller, L. H.; Baruch, D. I.; Marsh, K. and Doumbo, O. K. (2002), The pathogenic basis of malaria. Nature, 415, 673-679.
20. Owunwanne, A.; Patel, M. and Sadek, S. (1995), The handbook of radiopharmaceuticals. London: Chapman and Hall.
21. Owunwanne, A.; Shihab-Eldeen, A.; Vacoub, T. and Ziada, G. (1998), The use of radiopharmaceuticals as an effective toxicologic technique for studying nephrotoxicity of drugs: cyclosporine-A. Hum. Exp. Toxicol., 17, 613-619.
22. Palmer, K. J.; Holliday, S. M. and Brogden, R. N. (1993), Mefloquine - a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs, 45, 430-75.
23. Perkins, A. and Frier, M. (1999), Nuclear Medicine Pharmaceutical Research. London: Taylor and Francis.
24. Price, R. N. C.; Cassar, A.; Brockman, M.; Duraisingh, M.; van Vught, N. J.; White, F. and Krishna, S. (1999), The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother., 43, 2943-2949.
25. Schwartz, E.; Potasman, I.; Rotenberg, M.; Almog, S. and Sadetski, S. (2001), Serious adverse events of mefloquine in relation to blood level and gender. Am. J. Trop. Med. Hyg., 65, 189-192.
26. Sampson, C. B. (1993), Adverse reactions and drug interactions with radiopharmaceuticals. Drug Safety, 8, 280-294.
27. Sachs, J. and Malaney, P. (2002), The economic and social burden of malaria. Nature, 415: (7), 650-655.
28. Saha, G. B. (1998), Fundamentals of Nuclear Pharmacy. New York: Springer-Verlag.
29. 99mTc-MDP to blood cells and plasma proteins. Braz. J. Med. Biol. Res., 28, 131-135.
30. Trhall, J. H. and Ziessman, H. A. (2003), Medicina Nuclear. Rio de Janeiro: Guanabara-Koogan.
31. van Agtmael; M. A.; Eggelte, T. A. and van Boxtel, C. J. (1999), Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol. Sci., 20, 199-204.
32. White, N. J. (1999), Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc., 354, 739-749.
33. White, N. J. and Pongtavorndinya, W. (2003), The de novo selection of drug-resistant malaria parasites. Proc. R. Soc. Lond. Biol. Sci., 2, 67-71.
34. White, N. J. (2004), Antimalarial drug resistance. J. Clin. Invest., 113: (8), 1084-1092.
35. World Health Organization, Tropical Disease Research Division (2000), TDR News, 62, 1-20.
36. Xavier Holanda, C. M. C.; Cavalcanti Jales, R. L.; Almeida Catanho, M. T.; Holanda Leite, R.C.; Lopes de Britto, L. M.; Jales Jr., L. H.; Brandão, K. C.; Amorim, L. F, Brito Tiago, G. G.; Gomes, M. L. and Bernardo-Filho, M. (2002), Effects of the glucantime™ on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats. Cell. Mol. Biol., 48: (7), 761-765.